TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | 3 | 3 | -4 | -18 | -39 | 0 | -11 |
S | %wins | 0 | 25 | 75 | 100 | 100 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/24/17 18:07 | 3/23/17 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Vasisht Niraj | NC | O | SVP,CTO | S.d | -1 | 1.90 | 1 | -1 | 0 | 272 | D | -87 | -32 | -21 | 2 | -6 | -5 | -7 | 2 | 8 | 7 | -3 | |||
3/3/17 19:19 | 2/22/17 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Vasisht Niraj | NC | O | SVP,CTO | S.dm | -83 | 1.98 | 1 | -42 | -13 | 271 | D | -86 | -50 | -16 | 24 | 11 | 0 | 8 | 3 | 1 | -1 | -6 | |||
2/8/17 18:00 | 1/30/17 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Vasisht Niraj | NC | O | See Rema | S.d | -13 | 1.91 | 1 | -7 | -4 | 172 | D | -85 | -48 | -18 | 0 | 11 | 5 | 0 | 4 | 3 | 3 | 1 | -2 | ||
9/23/16 18:30 | 9/21/16 | BDSI | Biodelivery Sciences International Inc | DE | Health | Drug | Pharmaceutical Preparations | Vasisht Niraj | NC | O | CTO | S.dm | -114 | 2.43 | 1 | -47 | -22 | 162 | D | -85 | -63 | -18 | 3 | -8 | 0 | 0 | 0 | 1 | 1 | -9 | -34 | -39 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |